Search by Job Title

ScientistAdimab

THIS JOB HAS EXPIRED

Adimab is looking for an experienced mammalian cell culture and cell line development professional to join its team. The successful candidate will be responsible for generating stable mammalian cell lines and developing and optimizing in-house processes for rapid production of IgG antibodies at multi-liter scale.

Responsibilities

Develop stable, clonal cell lines for the expression of therapeutic antibodies
Develop and implement high-throughput and automated strategies to improve cell line development and recombinant protein titers
Develop and improve upon production of monoclonal antibodies and antigens
Oversee the work of 1-2 scientists
Qualifications

Ph.D. with 2-5 years or M.S. with 5+ years in an industrial biopharmaceutical, CMO, or biotechnology setting
Strong communication skills
Adaptable and productive in a fast-paced environment
Depth of technical knowledge in transient and stable mammalian expression systems and cell line development for recombinant protein production
Minimum of two years hands-on experience with mammalian cell line development for CHO and HEK cell lines and expression of recombinant proteins from suspension cultures
Strong technical knowledge in cell transfection, selection, protein expression, automated liquid handling, and cell-based analytical tools
Applied knowledge of mammalian genome editing tools such as ZFN?s, TALENs, or other is highly preferred
Experience with technical transfer and project management situations with an external partner is preferred
Experience supervising direct reports is preferred
Familiarity with cell culture medium development, bioreactor operations, and affinity purification FPLC is a plus
Adimab conducts antibody drug discovery for the world's top pharmaceutical companies. Adimab's yeast-based monoclonal antibody discovery platform functions like a synthetic human immune system to create novel antibody therapeutics across a broad range of diseases from cancer and autoimmune diseases to serious infectious diseases. Adimab is backed by top-tier venture capitalist firms including Google Ventures, OrbiMed Advisors, Polaris Venture Partners, SV Life Sciences, and Borealis Ventures.

Located in New Hampshire?s beautiful Upper Connecticut River Valley, Adimab is minutes from Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, the Tuck School of Business, and Dartmouth-Hitchcock Medical Center. Situated near the Appalachian Trail, the area is renowned for its premier skiing, hiking, canoeing, and kayaking.

Adimab offers individually tailored compensation packages comprised of competitive salary, bonus, and equity components, in addition to a world class working environment in a newly constructed lab.